Recursion Pharmaceuticals Inc (RXRX)
7.84
-0.10
(-1.26%)
USD |
NASDAQ |
Apr 25, 16:00
7.92
+0.08
(+1.02%)
After-Hours: 20:00
Recursion Pharmaceuticals Shareholders Equity (Quarterly): 463.44M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 463.44M |
| September 30, 2023 | 437.97M |
| June 30, 2023 | 468.96M |
| March 31, 2023 | 430.18M |
| December 31, 2022 | 485.81M |
| September 30, 2022 | 388.03M |
| June 30, 2022 | 437.58M |
| Date | Value |
|---|---|
| March 31, 2022 | 493.57M |
| December 31, 2021 | 542.94M |
| September 30, 2021 | 599.03M |
| June 30, 2021 | 642.71M |
| March 31, 2021 | -233.03M |
| December 31, 2020 | -206.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-233.03M
Minimum
Mar 2021
642.71M
Maximum
Jun 2021
380.84M
Average
463.44M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 10.77B |
| Palatin Technologies Inc | -11.38M |
| Oragenics Inc | 3.168M |
| Editas Medicine Inc | 349.10M |
| BioXcel Therapeutics Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 653.70M |
| Total Liabilities (Quarterly) | 190.26M |
| Debt to Equity Ratio | 0.0025 |
| Current Ratio | 4.702 |
| Net Debt Paydown Yield | -0.00% |